Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial

BACKGROUND: Ospemifene is a non-estrogen, tissue selective estrogen receptor agonist/antagonist, or selective estrogen receptor modulator, recently approved for the treatment of dyspareunia, a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Postmenopausal dyspareunia is often associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Constantine, G., Graham, S., Portman, D. J., Rosen, R. C., Kingsberg, S. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389697/
https://www.ncbi.nlm.nih.gov/pubmed/25252699
http://dx.doi.org/10.3109/13697137.2014.954996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389697/
https://www.ncbi.nlm.nih.gov/pubmed/25252699
http://dx.doi.org/10.3109/13697137.2014.954996

Ejemplares similares